Skip to content

Study to evaluate use of khadiradi kadha orally and khadiradi ointment loacaly on skin disease

Randomised Comparative Three Arm clinical study to evaluate the efficacy of Khadiradi Kashay orally, Khadiradi Raskriya Topically and Both combined together in Ekakushtha wsr to Psoriasis - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090590
Enrollment
60
Registered
2025-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Rushikesh Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group: - 18 to 60 years. 2) Patients with clinical features of EKA-KUSHTA having signs and symptoms namely Kandu (itching), Shushkta, Vaivarnya (Depigmentation),Mastyashakloptama (silvery patchy skin). 3) Patients of both Gender. 13 4) Patient who is willing to participate and in written provide in inform consent will be entertain in study.

Exclusion criteria

Exclusion criteria: 1) Patient suffering from any chronic skin disease, immune suppressed systemic disorders. 2) Patient suffering from any other systemic disorders like tuberculosis, diabetes melitus, HBsAg positive patients and known case of leprosy. 3) Pregnant & Lactating woman. 4) Psoriatic arthritis.

Design outcomes

Primary

MeasureTime frame
1. To study the efficacy of khadiradi Raskriya topically using PASI score in ekakustha. ( psoriasis ) 2. To study the efficacy of khadiradi kashaya orally using PASI score in ekakustha. . ( psoriasis ) Timepoint: 9 weeks

Secondary

MeasureTime frame
To compare the effect of khadiradi Raskriya topically with khadiradi kashaya orally in signs & symptoms of ekakustha. Timepoint: 9 weeks

Countries

India

Contacts

Public ContactDr Rushikesh Patil

Aarogyashala Rugnalaya

drhgarge@rediffmail.com9405366160

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026